Selecting the right microbial host is a critical first step in developing efficient cell factories for the production of fuels, chemicals, and pharmaceuticals.
This article explores the transformative impact of enzyme-constrained metabolic models (ecModels) compared to traditional genome-scale metabolic models (GEMs).
This article provides a comprehensive guide for researchers and drug development professionals on using Metabolic Flux Analysis (MFA) to identify critical bottlenecks in metabolic pathways.
This article provides a comprehensive overview of cutting-edge strategies to enhance microbial tolerance, a critical bottleneck in industrial biomanufacturing and antibiotic development.
This article provides a comprehensive analysis of the critical trade-offs between cellular growth and product formation in pharmaceutical development, a central challenge impacting the success and efficiency of biomanufacturing.
This article provides a comprehensive framework for researchers, scientists, and drug development professionals navigating the complex techno-economic challenges of commercial scaling.
Over-oxidation to undesired carbon oxides (COx) remains a fundamental challenge that limits the efficiency and economic viability of alkane conversion processes for producing valuable chemicals and biofuels.
This article explores k-OptForce, a computational framework that integrates kinetic modeling with stoichiometric Flux Balance Analysis (FBA) to optimize enzyme catalytic efficiency for metabolic engineering and drug development.
This comprehensive review addresses the critical challenge of metabolic burden in engineered microbial strains, a pervasive issue limiting productivity in industrial biotechnology.
The inherent recalcitrance of lignocellulosic biomass presents a fundamental barrier to the cost-effective production of second-generation biofuels.